XML 25 R14.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 9 - Acquisition of Nora
9 Months Ended
Sep. 30, 2018
Notes to Financial Statements  
Business Combination Disclosure [Text Block]
NOTE
9
– ACQUISITION OF NORA
 
    On
June 14, 2018,
the Company entered into a share purchase and transfer agreement to acquire the issued and outstanding shares of nora, nora’s outstanding
third
-party debt, and receivables related to nora’s shareholder loans. Nora is the holding company for a Germany-based manufacturer and multinational marketer of resilient floor coverings, including rubber flooring. In connection with the signing of the nora share purchase and transfer agreement, the Company entered into a derivative instrument to address the foreign currency risk associated with a portion of the nora purchase price. This option instrument did
not
qualify for hedge accounting, and the mark-to-market expense of
$2.8
million to record the instrument at fair value at the end of the
second
quarter of
2018
was recorded in other expense in our consolidated condensed statement of operations during the
second
quarter. The option instrument had a notional value of
€315
million (or approximately
$364
million as of the end of the
second
quarter of
2018
) and an initial maturity of
120
days. Upon completion of the nora acquisition as discussed below, the option instrument was terminated and the Company recognized a loss of approximately
$1.4
million upon termination, which was recorded in other expense in our Consolidated Condensed Statement of Operations during the
third
quarter of
2018.
 
   On
August 7, 2018,
the Company completed the acquisition of nora for a purchase price of
€385.1
million, or
$447.2
million at the exchange rate as of the transaction date, including acquired cash of
€40.0
million (
$46.5
million) for a net purchase price of
€345.1
million (
$400.7
million).
 
Nora is an industry leader in the rubber flooring market, and this acquisition is expected to advance the Company’s growth strategy in growing market segments, particularly in the healthcare, life sciences and education market segments.  Similar to Interface, nora operates on an international footprint and the Company expects the acquisition will also allow for geographic sales synergies as well. 
 
 The transaction will be accounted for as a business combination using the acquisition method of accounting, which requires, among other things, that assets acquired and liabilities assumed be recorded at their fair market values as of the acquisition date. The results of operations for this acquisition have been consolidated with those of the Company from the acquisition date forward.  Tangible assets and liabilities of nora systems GmbH were valued as of the acquisition date using a market analysis, and intangible assets were valued using a discounted cash flow analysis.
 
       The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the acquisition date. The amounts represent a provisional measurement of the fair values, and is therefore subject to change:
 
   
As of August 7
th
, 2018
 
   
(In thousands)
 
         
Cash
  $
46,495
 
Accounts receivables
   
30,996
 
Inventories
   
93,352
 
Other assets and prepaids
   
5,616
 
Property plant and equipment
   
79,538
 
Intangible assets
   
103,338
 
Total identifiable assets acquired
   
359,335
 
         
Current liabilities
   
(27,285
)
Deferred taxes
   
(29,277
)
Other long-term liabilities
   
(38,929
)
Total liabilities assumed
   
(95,491
)
Net identifiable assets acquired
   
263,844
 
Goodwill
   
183,348
 
Net assets acquired / cash paid
  $
447,192
 
 
        Acquired intangibles assets of
$103.3
million include
$60.8
million of trademarks and tradenames that are
not
subject to amortization and will instead be subject to annual impairment testing, or more frequent testing should there be a significant change in business conditions. The remaining intangible assets include developed technology of
$39.1
million that will be amortized on a straight-line basis over the estimated useful life of
7
years and backlog of
$3.4
million that will be amortized on a straight-line basis over the estimated useful life of
six
months. The inventory amount above includes a step-up of inventory to fair value of approximately
$26.6
million which will be recognized in earnings over the expected turns of the inventory. This step-up of inventory to fair value will be fully amortized by the end of
2018.
 
       As of
September 30, 2018,
the balances, net of accumulated amortization where applicable, of the acquired intangible assets from the nora acquisition were (in thousands):
 
Developed technology
  $
38,048
 
Trademarks and tradenames
   
59,880
 
Backlog
   
2,252
 
Goodwill
   
183,348
 
 
       As of
September 30, 2018,
the recognized goodwill of
$183.3
million and acquired intangible assets, net of amortization of
$100.2
million, were assigned pro-rata to the Company’s
three
operating segments.
None
of the goodwill is expected to be deductible for income tax purposes.
 
The fair value of acquired accounts receivable was
$30.1
million with the gross value being
$31.9
million. The Company expects
$1.8
million to be uncollectible.
 
       The Company recognized
$8.2
million of transaction costs related to the nora acquisition for the
nine
months ended
September 30, 2018.
Approximately
$4.0
million of these expenses are included in selling, general and administrative expenses in the consolidated condensed statement of operations and
$4.2
million are included in other expenses related to the derivative instrument the Company used to address the foreign currency risk associated with a portion of the nora purchase price. The Company also recognized
$8.8
million of debt issuance costs in connection with the amended and restated credit facility, which were recorded as a reduction of long-term debt in the consolidated condensed balance sheet.
 
     The amounts of revenue and net loss of nora included in the Company’s consolidated condensed statements of operations from the acquisition date to
September 30, 2018
are as follows (in thousands):
 
Revenue
  $
41,159
 
Net loss
   
(12,455
)
 
       The following represents the pro forma consolidated condensed statement of operations as if nora had been included in the consolidated results of the Company as of
January 1, 2017.
These are estimated for pro forma purposes only and do
not
necessarily reflect the results had nora been included as of the beginning of
2018
and
2017.
 
   
Pro Forma Consolidated Statement of Operations
 
   
(In thousands)
 
                 
   
Nine months ended
   
Nine months ended
 
   
September 30, 2018
   
October 1, 2017
 
Revenue
  $
1,001,919
    $
929,521
 
Net income
   
74,390
     
38,793
 
 
       Pro forma net income for the
nine
months ended
September 30, 2018,
excludes any transaction related costs as these are non-recurring costs for the combined Company.